CD14与痴呆发病及脑老化损伤标志物的关联
研究基于FHS和CHS两个社区队列,检测基线血浆可溶性CD14(sCD14)与痴呆发病、认知功能及MRI脑体积的关系。荟萃分析显示,sCD14每增加1个标准差,痴呆风险增加12%(95%CI 1.03-1.23;p=0.01)。sCD14升高还与加速脑老化的认知和MRI标志物相关。
要点
- sCD14每升高1个标准差,痴呆风险增加12%(95%CI 1.03-1.23;p=0.01)。
- sCD14升高与加速脑老化的认知和MRI标志物相关。
- sCD14是反映脑萎缩、认知下降和痴呆发病的炎症标志物。
核心结论
- sCD14是与脑萎缩、认知下降及痴呆发病相关的炎症标志物。
研究设计与样本
- 研究纳入FHS和CHS两个前瞻性社区队列,基线测量血浆sCD14并随访痴呆发病。
- FHS痴呆随访平均10年(SD 4),CHS平均6年(SD 3)。
- FHS有1588名参与者(平均年龄69±6岁,47%男性,131例新发痴呆事件)。
- CHS有3129名参与者(平均年龄72±5岁,41%男性,724例新发痴呆事件)。
主要发现
- 两队列荟萃分析显示,sCD14每增加1个标准差,痴呆风险增加12%(95%CI 1.03-1.23;p=0.01),校正年龄、性别、APOE ε4状态和血管危险因素。
- sCD14较高水平与两队列中多种加速脑老化的认知和MRI标志物相关。
- 在FHS中,sCD14较高水平还与脑萎缩进展更明显和执行功能下降相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the hypothesis that the inflammatory marker plasma soluble CD14 (sCD14) associates with incident dementia and related endophenotypes in 2 community-based cohorts. METHODS: Our samples included the prospective community-based Framingham Heart Study (FHS) and Cardiovascular Health Study (CHS) cohorts. Plasma sCD14 was measured at baseline and related to the incidence of dementia, domains of cognitive function, and MRI-defined brain volumes. Follow-up for dementia occurred over a mean of 10 years (SD 4) in the FHS and a mean of 6 years (SD 3) in the CHS. RESULTS: We studied 1,588 participants from the FHS (mean age 69 ± 6 years, 47% male, 131 incident events) and 3,129 participants from the CHS (mean age 72 ± 5 years, 41% male, 724 incident events) for the risk of incident dementia. Meta-analysis across the 2 cohorts showed that each SD unit increase in sCD14 was associated with a 12% increase in the risk of incident dementia (95% confidence interval 1.03-1.23; p = 0.01) following adjustments for age, sex, APOE ε4 status, and vascular risk factors. Higher levels of sCD14 were associated with various cognitive and MRI markers of accelerated brain aging in both cohorts and with a greater progression of brain atrophy and a decline in executive function in the FHS. CONCLUSION: sCD14 is an inflammatory marker related to brain atrophy, cognitive decline, and incident dementia.
引用
- Pase MP, Himali JJ, Beiser AS, et al. Association of CD14 with incident dementia and markers of brain aging and injury. Neurology. 2019. PMID: 31818907. doi:10.1212/WNL.0000000000008682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。